Submitted by Anonymous (not verified) on 10 June 2025 - 16:33
Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0130/2024
Source: